Product Name: AHA1
Product Number: AB-NN191-3
Size: | 25 µg | | Price: | 89.00 |
| | | $US | |
Target Full Name: Activator of 90 kDa heat shock protein ATPase homologue 1
Target Alias: Aha 1; Ahsa1; p38; HSPC322; C14orf3; Activator of HSP90 ATPase;
Product Type Specific: AHA1 pan-specific antibody
Antibody Code: NN191-3
Antibody Target Type: Pan-specific
Protein UniProt: O95433 Protein SigNET: O95433 Antibody Type: Monoclonal
Antibody Host Species: Mouse
Antibody Ig Isotype Clone: IgG1 Kappa
Antibody Immunogen Source: Human Aha1, his tagged
Production Method: Protein G purified
Antibody Modification: Unconjugated. Contact KInexus if you are interest in having the antibody biotinylated or coupled with fluorescent dyes.
Antibody Concentration: 1 mg/ml
Storage Buffer: Phosphate buffered saline pH7.2, 50% glycerol, 0.09% sodium azide
Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.
Product Use: Western blotting | ELISA
Antibody Dilution Recommended: WB (1:1000); optimal dilutions for assays should be determined by the user.
Scientific Background: Aha1 is a member of the HSP90 cochaperone family, and is thought to stimulate HSP90 ATPase activity by competing with p23 and other co-chaperones for HSP90 binding (1, 2). It may affect a step in the endoplasmic reticulum to Golgi trafficking. Aha1 also interacts with HSPCA/HSP90 and with the cytoplasmic tail of the vesicular stomatistis virus glycoproteins (VSV G) (3). Aha1 is expressed in numerous tissues, including the brain, heart, skeletal muscle, and kidney, and at low levels, the liver and placenta. Aha1 might be a potential therapeutic strategy to increase sensitivity to HSP inhibitors (4).
References[1] Hainzl O., Lapina M.C., Buchner J., Richter K. (2009) J Biol Chem. Epub.[2] Harst A., Lin H., Obermann W.M. (2005) Biochem J. 387 (pt.3): 789-796.[3] Lotz G.P., Brychzy A., Heinz S., Obermann W.M. (2008) J Cell Sci. 121(pt.5): 717-723.[4] Holmes J.L., Sharp S.Y., Hobbs S., Workman P. (2008) Cancer Res. 68(4): 1188-1197.